2021 Advanced Diabetes Technology Guideline
AACE Endocrine Practice Guideline Diabetes

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus

AACE Co-Chairs, guideline task force experts, George Grunberger, MD, FACP, MACE, and Jennifer Sherr, MD, PhD, released the advanced diabetes technology guideline, Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus, at our 2021 Annual MeetingThis guideline provides recommendations based on scientific evidence for health care professionals in the safe and effective use of advanced diabetes technology. While many persons with diabetes use self-monitoring of blood glucose and insulin injections or insulin pens, these tools are being replaced by more advanced technologies that provide more useful data and greater convenience. Advanced tools, such as continuous glucose monitors (CGMs), provide data in real time to help persons with diabetes avoid experiencing low and high blood sugar levels. Diabetes technology is rapidly changing and improving and can be beneficial for all those living with diabetes.

Read the evidence-based guideline for recommendations on the use of advanced technology in the management of persons with diabetes mellitus, including: 

  • Clinical use of continuous glucose monitors (CGM) 
  • Continuous subcutaneous insulin infusion via insulin pumps 
  • Integrated systems (insulin pump - CGM)
  • What health care professionals need to know in terms of safety & much more!

To learn more, listen to Dr. Grunberger and Dr. Sherr present their key takeaways of the advanced diabetes technology guideline on the AACE podcast channel here

Published as Article in Press on www.endocrinepractice.org and will be published in Volume 27, Issue 6, June 2021 Endocrine Practice.